COX-2 expression has been associated with a lower apoptotic index [34], increased cell proliferation [35], increased risk of metastasis [36], [37], and enhanced VEGF production, leading to angiogenesis in pancreatic tumors [38], [39]. The gene discussed is VEGFA; the disease is pancreatic neoplasm.